Interleukin-11 fusion proteins

Details for Australian Patent Application No. 2004295171 (hide)

International Classifications

Event Publications

9 November 2006 Section 223 Application Allowed

Delta Biotechnology Limited The time in which to enter the National Phase has been extended to 03 Aug 2006. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000 2005

16 November 2006 PCT application entered the National Phase

PCT publication WO2005/054286 Priority application(s): WO2005/054286

21 December 2006 Change of Name(s) of Applicant(s), Section 104

Delta Biotechnology Limited The name of the applicant has been changed to Novozymes Delta Limited Change of Name(s) of Applicant(s), Section 104 2005

7 January 2010 Alteration of Name

The name of the applicant has been altered to Novozymes Biopharma UK Limited

9 September 2010 Assignment before Grant

Novozymes Biopharma UK Limited The application has been assigned to Novozymes Biopharma DK A/S 2005

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.